Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 8 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-05-24 Abdun-Nabi Daniel Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-05-24 Tasse Daniel Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-05-24 HAYDEN DONALD J JR Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-05-24 BESHAR LUKE M Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-05-24 STUMP DAVID C Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-05-24 Fox Allan M. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-05-24 KARABELAS ARGERIS N Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2017-05-15 HAYDEN DONALD J JR Director Sale −8,599 $19.04 $164K 0
2017-05-15 Vasista Vittal Chief Financial Officer Sale −3,100 $19.07 $59K 110,612
2017-05-08 HAYDEN DONALD J JR Director Sale −10,000 $18.35 $184K 8,599
2017-05-01 HAYDEN DONALD J JR Director Exercise or conversion +20,000 $0.85 $17K 48,599
2017-05-01 HAYDEN DONALD J JR Director Sale −4,738 $21.34 $101K 43,861
2017-05-01 HAYDEN DONALD J JR Director Sale −25,262 $22.43 $567K 18,599
2017-05-01 HAYDEN DONALD J JR Director Exercise or conversion · Stock Option (Right to Buy) −20,000 251,382
2017-04-24 Mills Kenneth T. President and CEO Sale −14,045 $20.94 $294K 126,395
2017-04-24 Mills Kenneth T. President and CEO Sale −1,395 $21.40 $30K 125,000
2017-04-24 HAYDEN DONALD J JR Director Sale −10,000 $20.98 $210K 28,599
2017-04-24 Vasista Vittal Chief Financial Officer Sale −2,773 $20.95 $58K 114,039
2017-04-24 Vasista Vittal Chief Financial Officer Sale −327 $21.42 $7K 113,712
2017-03-27 Danos Olivier Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000

Page 48 of 56 · 1,104 trades